Pharmabiz
 

U.SK, Dermatology to market Sonoma Pharma's dermatology products in Brazil

Sao Paulo, BrazilThursday, June 7, 2018, 17:00 Hrs  [IST]

U.SK Dermatology, the dermatology arm of NC Group, and Sonoma Pharmaceuticals, Inc., a specialty pharmaceutical company,  have entered into a license and supply partnering agreement for the exclusive distribution of multiple Sonoma dermatology products into Brazil, including:  GramaDerm hydrogel  – for acne; GramaDerm liquid– for acne;  Celacyn – as a scar treatment; Pediacyn spray– for atopic dermatitis treatment;  Pediacyn gel – for atopic dermatitis treatment;  Lasercyn spray– for skin cleansing following cosmetic procedures; Lasercyn hydrogel – for skin cleansing following cosmetic procedures.

“Having access to Sonoma’s HOCl-based technology provides us with the first-ever hypochlorous acid-based products in the Brazilian dermatology market.  We believe the integration of these products into U.SK Dermatology’s portfolio of strong brands and supporting Brazilian dermatologist’s treatment protocols will improve patient outcomes relative to various afflictions,” said Jailson Bispo, U.SK CEO.

“We are thrilled to partner with U.SK Dermatology, who shares our vision of providing alternate dermatology solutions to topical antibiotics and steroids.  U.SK has demonstrated they can successfully compete and win in the Brazilian dermatology market against multi-national pharmaceutical companies,” said Jim Schutz, Sonoma’s CEO.

NC Group, with over $3 billion in annual revenues and strong go-to-market capabilities, will market and sell Sonoma’s hypochlorous acid-based products to dermatologists and pharmacies throughout Brazil under its dermatology arm U.SK Dermatology.  Sonoma and U.SK have been working closely on a launch plan that leverages Sonoma’s U.S. dermatology success in combination with U.SK and NC Group’s history of successful execution in the Brazilian market.  First products are expected to hit the market in August 2018.

According to a research report from IQVIA, the Brazilian dermatology market is $1.5 billion in sales annually and has grown at an annual rate of 10% over the past five years.

NC Group is a Brazilian holding company with over 50 years of successful operations across several economic sectors, such as pharmaceuticals, energy, media and real estate.  With headquarters in the city of Hortolandia in São Paulo state, NC Group employs over seven thousand employees and has more than ten companies under its umbrella.

Sonoma is a specialty pharmaceutical company that develops and markets unique and effective solutions for the treatment of dermatological conditions and advanced tissue care.

 
[Close]